Skip Nav Destination
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories
Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect
Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
Issue Archive
Table of Contents
INSIDE BLOOD
CLINICAL OBSERVATIONS, INTERVENTIONS, & THERAPEUTIC TRIALS
Childhood stroke frequency decreased in California during 1999 and 2000
PLENARY PAPERS
Genetic evidence for lineage-related and differentiation stage–related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia
Marco Tartaglia,Simone Martinelli,Giovanni Cazzaniga,Viviana Cordeddu,Ivano Iavarone,Monica Spinelli,Chiara Palmi,Claudio Carta,Andrea Pession,Maurizio Aricò,Giuseppe Masera,Giuseppe Basso,Mariella Sorcini,Bruce D. Gelb,Andrea Biondi
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial
Clinical Trials & Observations
Nicole Casadevall,Pierre Durieux,Stéphanie Dubois,François Hemery,Eric Lepage,Marie-Catherine Quarré,Gandhi Damaj,Stéphane Giraudier,Agnès Guerci,Guy Laurent,Hervé Dombret,Christine Chomienne,Vincent Ribrag,Aspasia Stamatoullas,Jean-Pierre Marie,Anne Vekhoff,Frédéric Maloisel,Robert Navarro,François Dreyfus,Pierre Fenaux,for the Groupe Français des Myélodysplasies
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories
Clinical Trials & Observations
GENE THERAPY
A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome–positive acute lymphoblastic leukemia
Yasushi Soda,Kenzaburo Tani,Yuansong Bai,Minoru Saiki,Minghan Chen,Kiyoko Izawa,Seiichiro Kobayashi,Satoshi Takahashi,Kaoru Uchimaru,Tomoko Kuwabara,Masaaki Warashina,Tsuyoshi Tanabe,Hiroyuki Miyoshi,Kanji Sugita,Shinpei Nakazawa,Arinobu Tojo,Kazunari Taira,Shigetaka Asano
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect
Clinical Trials & Observations
Angela Gismondi,Loredana Cifaldi,Cinzia Mazza,Silvia Giliani,Silvia Parolini,Stefania Morrone,Jordan Jacobelli,Elisabetta Bandiera,Luigi Notarangelo,Angela Santoni
Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome
Clinical Trials & Observations
Anna Virginia Gulino,Daniele Moratto,Silvano Sozzani,Patrizia Cavadini,Karel Otero,Laura Tassone,Luisa Imberti,Silvia Pirovano,Lucia D. Notarangelo,Roberta Soresina,Evelina Mazzolari,David L. Nelson,Luigi D. Notarangelo,Raffaele Badolato
HIV-1–specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor–α
Mathias Lichterfeld,Xu G. Yu,Michael T. Waring,Stanley K. Mui,Mary N. Johnston,Daniel Cohen,Marylyn M. Addo,John Zaunders,Galit Alter,Eunice Pae,Daryld Strick,Todd M. Allen,Eric S. Rosenberg,Bruce D. Walker,Marcus Altfeld
NEOPLASIA
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner
Meritxell Alberich Jordà,Nazik Rayman,Marjolein Tas,Sandra E. Verbakel,Natalia Battista,Kirsten van Lom,Bob Löwenberg,Mauro Maccarrone,Ruud Delwel
PHAGOCYTES
TRANSPLANTATION
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
Clinical Trials & Observations
Corey S. Cutler,Stephanie J. Lee,Peter Greenberg,H. Joachim Deeg,Waleska S. Pérez,Claudio Anasetti,Brian J. Bolwell,Mitchell S. Cairo,Robert Peter Gale,John P. Klein,Hillard M. Lazarus,Jane L. Liesveld,Philip L. McCarthy,Gustavo A. Milone,J. Douglas Rizzo,Kirk R. Schultz,Michael E. Trigg,Armand Keating,Daniel J. Weisdorf,Joseph H. Antin,Mary M. Horowitz
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals